[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Lebanese American University\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":155},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,43,76,102,127],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100563769","assessing-the-enhanced-precision-the-value-of-impedance-in-ultrasound-guided-nerve-blocks-axillary-interscalene-popliteal-sciatic-an-exploratory-prospective-observational-study-100563769",false,"NCT06620471","Assessing the Enhanced Precision: The Value of Impedance in Ultrasound-Guided Nerve Blocks (Axillary, Interscalene, Popliteal Sciatic), an Exploratory Prospective Observational Study","Assessing the Enhanced Precision: The Value of Impedance in Ultrasound-Guided Nerve Blocks, an Exploratory Prospective Observational Study","Inclusion Criteria:\n\n* Individuals aged 18 years to 90 years old\n* No infection at the injection site\n* Patient signed the study consent form\n* No contraindications for nerve block\n* No allergies to any of the drugs used\n* Patient able to communicate effectively\n\nExclusion Criteria:\n\n* Patients not meeting the inclusion criteria\n* Patients with bleeding disorders or undergoing anticoagulation therapy\n* Pregnant patients\n* Patients with mental incapacity\n* Any medical conditions posing severe risks during the procedure","ALL","18 Years","90 Years",{"count":20,"type":21},100,"ESTIMATED","OBSERVATIONAL","Impedance can have an impact on nerve block during loco-regional anesthesia, particularly when using techniques such as nerve stimulation or ultrasound guidance to locate and block specific nerves. Impedance refers to the resistance to electrical current flow within tissue, and it can affect the ability to stimulate nerves or visualize them using ultrasound. The aim of this research is to assess the impedance across different tissue type during an axillary peripheral nerve block (skin, fat, fascia, muscle, nerve proximity). The results of this study would help clinicians performing nerve block to enhance the precision of needle placement, thus increase the success rate of nerve block and reduce adverse events such as intraneural or intravascular injections.",[25,26,27,28,29],"Impedance","Axillary Nerve Block","Ultrasound-Guided Nerve Blocks","Interscalene Nerve Block","Popliteal Sciatic Nerve Block","RECRUITING","2026-05-18",{"date":33,"type":34},"2026-05-20","ACTUAL",{"date":36,"type":34},"2024-06-10",{"date":38,"type":21},"2026-12",{"name":40,"class":41},"Lebanese American University","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":51,"sex":16,"minAge":17,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":55,"phases":56,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":42},"100612033","production-and-evaluation-of-an-evidence-based-health-awareness-video-on-precautionary-measures-against-respiratory-infectious-diseases-hav-rid-study-100612033","NCT07248319","Production and Evaluation of an Evidence-based Health Awareness Video on Precautionary Measures Against Respiratory Infectious Diseases (HAV-RID Study)","Production and Evaluation of an Evidence-based Health Awareness Video on Precautionary Measures Against Respiratory Infectious Diseases: A Randomized Controlled Trial on Public Transportation Drivers in Lebanon (HAV-RID Study)","(HAV-RID)","Inclusion Criteria:\n\n* Public transportation drivers who operate within the Lebanese public transportation system, regardless of their nationality or gender.\n\nExclusion Criteria:\n\n* Commercial drivers (trucks) or others who are not in a daily contact with commuters.\n* Drivers who are unwilling to enroll in the study or unable to comprehend written\u002Fverbal Arabic language will be excluded.",true,"65 Years",{"count":54,"type":21},160,"INTERVENTIONAL",[57],"NA","Health awareness videos are integral in disseminating knowledge about respiratory infectious diseases (RIDs). The aim of this study is to produce and evaluate an evidence-based health awareness video on precautionary measures against respiratory infectious diseases among public transportation drivers in Lebanon. You will be asked to watch a newly produced health-awareness video, then we will test your knowledge about respiratory infectious diseases , health-risk perceptions, attitude towards vaccination, and cognitive dissonance. Public transportation drivers are eligible to enroll if they operate within the Lebanese public transportation system, regardless of their gender. A proportionate sample of drivers will be invited to enroll from various Lebanese regions. The experimental group (n=80) will watch a health-awareness video, whereas the control group (n=80) will watch a neutral video on traffic signs. Participants' knowledge about RID, health-risk perceptions, attitude towards vaccination, and cognitive dissonance will be evaluated. The trial study will be conducted in community settings where public transportation drivers are naturally present (transportation stations, parking lots). A written informed consent will be sought. Data will be electronically recorded. Data will remain anonymous during data entry\u002Fanalyses. An incentive will be provided.",[60],"Produce and Evaluate an Evidence-based Health Awareness Video",[62,63,64,65,66],"influenza","covid-19","transportation","health awareness video","Lebanon","NOT_YET_RECRUITING","2025-11-18",{"date":70,"type":34},"2025-11-25",{"date":72,"type":21},"2026-03-01",{"date":74,"type":21},"2028-03-01",{"name":40,"class":41},{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":4,"eligibilityCriteria":82,"healthyVolunteers":11,"sex":16,"minAge":83,"maxAge":84,"enrollmentInfo":85,"targetDuration":4,"studyType":55,"phases":87,"briefSummary":89,"conditions":90,"keywords":4,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":4},"100591555","phase-4-addition-of-dexmedetomidine-to-ropivacaine-in-bilateral-erector-spinae-plane-block-in-patients-undergoing-coronary-artery-bypass-surgery-100591555","NCT06981949","Addition of Dexmedetomidine to Ropivacaine in Bilateral Erector Spinae Plane Block in Patients Undergoing Coronary Artery Bypass Surgery","The Addition of Dexmedetomidine to Ropivacaine in Bilateral Erector Spinae Plane Block in Patients Undergoing Coronary Artery Bypass Surgery - A Double-blinded Randomized Clinical Trial","Inclusion Criteria:\n\n1. Age range: 25 - 80 years old\n2. Planned for elective OFF PUMP CABG\n3. Cognitively not impaired\n4. American Society of Anesthesiologists class 3\n5. Left ventricular ejection fraction ≥40%\n6. Consent form for the study signed\n7. No infection at the site of injection\n8. No contraindication for ESP block (thrombocytopenia, anticoagulation therapy)\n9. No documented allergy to ropivacaine or dexmedetomidine\n\nExclusion Criteria:\n\n1. Refusal to participate in the study\n2. Emergency surgery\n3. American Society of Anesthesiologists class \\>3\n4. Left ventricular ejection fraction \\\u003C40%\n5. Infection at the site of injection for ultrasound-guided ESPB\n6. Coagulation disorders\n7. Documented allergy to ropivacaine or dexmedetomidine\n8. Greater than first-degree heart block\n9. Bradycardia (heart rate \\[HR\\] \\\u003C 50 bpm)\n10. Pregnancy\n11. BMI ≥40\n12. Psychiatric illnesses that would interfere with the assessment of pain scores\n13. History of alcohol or drug abuse and chronic analgesic use","25 Years","80 Years",{"count":86,"type":21},110,[88],"PHASE4","Coronary artery bypass surgery (CABG), typically performed through a median sternotomy, causes significant postoperative pain. Managing this pain effectively while reducing reliance on opioids is essential, as opioids can lead to side effects such as respiratory depression, nausea, and potential for dependence. Regional anesthesia techniques like the erector spinae plane block (ESPB) have emerged as promising tools to control pain and support recovery.\n\nThis randomized, double-blind clinical trial evaluates whether adding dexmedetomidine, a sedative and analgesic, to ropivacaine, a local anesthetic, in bilateral ESPB can improve pain control after off-pump CABG surgery. The study is conducted at the Lebanese American University Medical Center - Rizk Hospital.\n\nA total of 110 adult patients undergoing elective surgery are randomly assigned to one of two groups:\n\n1. Group R: Receives ropivacaine alone in the ESPB.\n2. Group RD: Receives ropivacaine with dexmedetomidine.\n\nThe nerve block is administered before anesthesia. The primary outcome is the duration of effective pain relief (pain score ≤4) before the patient needs opioid medication, assessed up to 24 hours after extubation.\n\nSecondary outcomes include:\n\n1. Pain scores monitored for up to 48 hours post-extubation\n2. Total intraoperative opioid use\n3. Time to extubation, ambulation, and incentive spirometry use\n4. ICU stay duration\n5. Side effects such as nausea, bradycardia, or local anesthetic toxicity\n\nThis study supports efforts to reduce opioid use after heart surgery while maintaining effective pain management, aligning with enhanced recovery protocols and addressing the broader public health challenge of opioid overuse.",[91,92,93],"Pain","Pain Management Following Cardiopulmonary Bypass Surgery","Erector Spinae Plane Block","2025-05-17",{"date":96,"type":34},"2025-05-21",{"date":98,"type":21},"2025-05-15",{"date":100,"type":21},"2026-05-16",{"name":40,"class":41},{"id":103,"slug":104,"hasResults":11,"nctId":105,"briefTitle":106,"officialTitle":107,"acronym":108,"eligibilityCriteria":109,"healthyVolunteers":51,"sex":16,"minAge":110,"maxAge":4,"enrollmentInfo":111,"targetDuration":4,"studyType":55,"phases":113,"briefSummary":114,"conditions":115,"keywords":4,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":119,"lastUpdatePostDateStruct":120,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":4},"100589864","low-cost-model-versus-airway-part-task-trainer-for-flexible-bronchoscope-guided-tracheal-intubation-training-100589864","NCT06959953","Low-Cost Model Versus Airway Part-Task Trainer for Flexible Bronchoscope-Guided Tracheal Intubation Training","Low-cost Model Versus Airway Part-task Trainer for Flexible Bronchoscope-guided Tracheal Intubation Training: A Multicenter, Non-inferiority, Simulation-based Trial Among Anesthesiology Residents in Lebanon","RAN","Phase 1: Expert committee Intermediate phase: Postgraduate fellows and residents from pulmonology and ENT, along with senior anesthesia residents Phase 2: Inclusion criteria include PGY 1 and 2 levels with no previous experience with FBTI and belonging to one of the eight prespecified medical centers. Any resident with prior exposure and experience with FBTI will be excluded.","24 Years",{"count":112,"type":21},53,[57],"Background: Awake flexible bronchoscope-guided tracheal intubation (FBTI) is crucial in managing challenging airway situations. As the gold standard for difficult airway management, FBTI is essential for anesthesiologists to navigate anatomical complexities effectively.\n\nTraining in FBTI requires theoretical understanding, hands-on practice, and experience. Skill acquisition and knowledge must reach an appropriate level before trainees perform on patients. Simulated scenarios offer a controlled environment for practitioners to develop muscle memory and problem-solving skills without risking patient safety. However, commercial simulators for FBTI are often expensive and inaccessible in many countries. Lebanon, a low- and middle-income country, currently faces a multifaceted economic and financial crisis. Hence, securing enough internal funds to support novice learners using available high-cost simulator training is challenging. Various low-cost simulators have been proposed in the literature, aiming to provide affordable training for novice anesthesiologists, particularly in regions where expensive simulators are scarce.\n\nAim: This study aims to evaluate a low-cost, locally designed simulator by comparing skill acquisition and retention to a commercial airway part-task trainer in FBTI.\n\nStudy design: Multicenter simulation-based randomized controlled trial (RCT) Methods: This simulation-based interventional clinical trial will include anesthesia PGY-I and PGY-II residents inexperienced in FBTI techniques from eight medical schools in Lebanon. The study comprises two main phases and one intermediate phase. Phase one is the development phase, whereby a Delphi approach will be utilized to develop a standardized Global Rating Scale for FBTI (LAU-modified SGR). The intermediate phase constitutes piloting the tool developed with LAU postgraduate trainees years 3, 4, and 5 from the pulmonology department, Ear, Nose, and Throat department, along with the anesthesiology residents. Phase two is the main RCT study whereby all participating residents will receive training on a theoretical course covering flexible bronchoscopy equipment, anatomy, indications, and complications, which will also be supplemented by a procedural video. After which residents will be randomly assigned to one of two groups. One group will undergo training on the locally designed low-cost model (RAN), whereas the other group will train on the airway part-task trainer. Participants' FBTI skills will be assessed using the high-fidelity CAS simulator and the LAU-modified SGR for FBTI to evaluate both theoretical and procedural fluency (i.e., retention of FBTI skills). Assessments will be conducted immediately after the training sessions, with follow-ups at three and six months.\n\nSignificance: The utilization of low-cost simulators enables the integration of simulation training for healthcare professionals across diverse settings, facilitating skill transfer to clinical practice effectively at the lowest cost possible.",[116,117,118],"Simulation Based Medical Education","Tracheal Intubation","Medical Residents","2025-05-04",{"date":121,"type":34},"2025-05-07",{"date":123,"type":21},"2025-06",{"date":125,"type":21},"2026-07",{"name":40,"class":41},{"id":128,"slug":129,"hasResults":11,"nctId":130,"briefTitle":131,"officialTitle":132,"acronym":4,"eligibilityCriteria":133,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":134,"targetDuration":4,"studyType":55,"phases":136,"briefSummary":137,"conditions":138,"keywords":141,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":147,"lastUpdatePostDateStruct":148,"startDateStruct":150,"completionDateStruct":152,"leadSponsor":154,"locationsCount":42},"100587719","plado-for-conservative-management-of-ckd-100587719","NCT06932042","PLADO for Conservative Management of CKD","Plant Dominant Low-protein Diet for Conservative Management of Chronic Kidney Disease: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients aged 18 years and above, having controlled glycemic and blood pressure parameters on treatment, with an established diagnosis of stages 3-5 CKD and an estimated GFR ≤59 ml\u002Fmin\u002F1.73 m2 stable for at least three months, and with a normal nutritional status as defined by the GLIM criteria, attending the CKD outpatient clinics at LAUMC-RH, willing to undergo the baseline screening and attend the monthly face-to-face visits at the outpatient department at LAUMC-RH.\n\nExclusion Criteria:\n\n* Patients with overt infection, persistent anorexia, vomiting, or diarrhea within the last month, presence of wasting diseases such as cancer, tuberculosis, liver failure, heart failure, and those with serum potassium \\>5.5 mEq\u002FL during the past 6 months.",{"count":135,"type":21},48,[57],"The goal of this clinical trial is to learn if a plant-dominant low protein diet, referred to as PLADO diet, works to decrease metabolic acidosis, a major risk factor for chronic kidney disease (CKD) progression, in adults with CKD. It will also learn about the safety, viability, and economic attractiveness of this diet.\n\nThe main questions it aims to answer are:\n\n* Is the PLADO diet more effective in managing metabolic acidosis in comparison with the standard-of-care CKD diet in adults with CKD?\n* Is the PLADO diet safe, viable, and economically attractive adults with CKD?\n\nResearchers will compare the PLADO diet to the standard-of-care CKD diet to see if the PLADO diet works better to decrease metabolic acidosis.\n\nParticipants will:\n\n* Receive nutrition education of the PLADO diet or the standard-of-care CKD diet via monthly sessions for 6 months.\n* Visit the clinic monthly for 6 months, then after 3 months for checkups and tests.",[139,140],"Chronic Kidney Disease(CKD)","Metabolic Acidosis",[142,143,144,145,146],"Chronic kidney disease","metabolic acidosis","PLADO","Plant-dominant low protein diet","Nutrition education","2025-04-09",{"date":149,"type":34},"2025-04-17",{"date":151,"type":34},"2024-05-28",{"date":153,"type":21},"2026-06-30",{"name":40,"class":41},""]